Are you an adult or adolescent with Sickle Cell Disease? The HIBISCUS Study is testing a new investigational treatment!
We are looking for people age 12 to 65 years old with SCD to help test a drug trying to reduce the number of vaso-occlusive crises
a study on Sickle Cell Anemia Anemia
- for people ages 12-65 (full criteria)
- at Sacramento, California and other locations
- study startedestimated completion
Sickle Cell Disease, Sickle Cell, Anemia, Sickle Cell Anemia, Hemolytic, Hemoglobin, Vaso-occlusive Crisis, Sickle Cell Crisis, Congenital Anemia, Hemolytic Anemia, Hematologic Disease, Hemoglobinopathies, Genetic Disease, Inborn Disease, Sickle Cell Trait, Pyruvate Kinase, Etavopivat Tablets Low dose, Etavopivat Tablets High dose, Etavopivat Tablets, Open label etavopivat
- accepting new patients
- Start Date
- Completion Date
- Forma Therapeutics, Inc.
- Sign up for this study
- Phase 2/3 research study
- Study Type
- Expecting 344 study participants
- Last Updated